Disease burden of foodborne pathogens in the Netherlands, 2009

International Journal of Food Microbiology

Volumn 156, Issue 3, 2012, Pages 231-238

  Havelaar, Arie H ^a,b   Haagsma, Juanita A ^a,c   Mangen, Marie Josée J ^a,d   Kemmeren, Jeanet M ^a   Verhoef, Linda P B ^a   Vijgen, Sylvia M C ^a,e   Wilson, Margaret ^f   Friesema, Ingrid H M ^a   Kortbeek, Laetitia M ^a   van Duynhoven, Yvonne T H P ^a   van Pelt, Wilfrid ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e Health Care Insurance Board ^*  (Netherlands)

^f Risk Sciences International   (Canada)

Author keywords

Attribution; Burden of disease; Foodborne diseases; Gastroenteritis

Indexed keywords

ARTICLE; CAMPYLOBACTER; COHORT ANALYSIS; CONGENITAL TOXOPLASMOSIS; CONSULTATION; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; ENVIRONMENTAL FACTOR; FOOD POISONING; FOOD QUALITY; GASTROENTERITIS; GENERAL PRACTITIONER; HOSPITAL ADMISSION; HUMAN; INCIDENCE; LIFE EXPECTANCY; LISTERIOSIS; NETHERLANDS; NONHUMAN; NOROVIRUS; RISK MANAGEMENT; ROTAVIRUS; SALMONELLA; TOXOPLASMA GONDII; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; BACTERIAL INFECTIONS; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COST OF ILLNESS; DISABLED PERSONS; FOODBORNE DISEASES; HUMANS; INCIDENCE; INFANT; LISTERIOSIS; MALE; MIDDLE AGED; NETHERLANDS; NOROVIRUS; POPULATION SURVEILLANCE; PUBLIC HEALTH; QUALITY-ADJUSTED LIFE YEARS; RISK ASSESSMENT; SALMONELLA; SALMONELLA INFECTIONS;

CAMPYLOBACTER; PROTOZOA; ROTAVIRUS; SALMONELLA; TOXOPLASMA GONDII;

EID: 84861001014     PISSN: 01681605     EISSN: 18793460     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2012.03.029     Document Type: Article

References (57)

1. Adak G.K., Long S.M., O'Brien S.J. Trends in indigenous foodborne disease and deaths, England and Wales: 1992 to 2000. Gut 2002, 51:832-841.
2. Adak G.K., Meakins S.M., Yip H., Lopman B.A., O'Brien S.J. Disease risks from foods, England and Wales, 1996-2000. Emerging Infectious Diseases 2005, 11:365-372.
3. Anonymous Guide to the Methods of Technology Appraisal 2008, National Institute for Health and Clinical Excellence, London.
4. Aouaj Y., Spanjaard L., Van Leeuwen N., Dankert J. Listeria monocytogenes meningitis: serotype distribution and patient characteristics in The Netherlands, 1976-95. Epidemiology and Infection 2002, 128:405-409.
5. Batz M.B., Hoffmann S., Morris J.G. Ranking the Risks: the 10 Pathogen-Food Combinations with the Greatest Burden on Public Health 2011, Emerging Pathogens Institute, University of Florida, Gainesville, FL.
6. Borgen K., Herremans T., Duizer E., Vennema H., Rutjes S., Bosman A., de Roda Husman A.M., Koopmans M. Non-travel related Hepatitis E virus genotype 3 infections in the Netherlands; a case series 2004-2006. BMC Infectious Diseases 2008, 8:61.
7. Burnett A.J., Shortt S.G., Isaac-Renton J., King A., Werker D., Bowie W.R. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology 1998, 105:1032-1037.
8. De Wit M.A.S., Koopmans M.P.G., Kortbeek L.M., Van Leeuwen N.J., Bartelds A.I.M., Van Duynhoven Y.T.H.P. Gastroenteritis in sentinel general practices, The Netherlands. Emerging Infectious Diseases 2001, 7:82-91.
9. De Wit M.A.S., Koopmans M.P.G., Kortbeek L.M., Van Leeuwen N.J., Vinje J., Van Duynhoven Y.T.H.P. Etiology of gastroenteritis in sentinel general practices in the Netherlands. Clinical Infectious Diseases 2001, 33:280-288.
10. De Wit M.A.S., Koopmans M.P.G., Kortbeek L.M., Wannet W.J., Vinje J., Van Leusden F., Bartelds A.I.M., van Duynhoven Y.T.H.P. Sensor, a population-based cohort study on gastroenteritis in the Netherlands: incidence and etiology. American Journal of Epidemiology 2001, 154:666-674.
11. Doorduyn Y., Van Pelt W., Havelaar A.H. The burden of infectious intestinal disease (IID) in the community-a survey of self-reported IID in the Netherlands. Epidemiology and Infection 2011, (Electronic publication ahead of print). doi:10.1017/S0950268811001099.
12. European Food Safety Authority; European Centre for Disease Prevention and Control Trends and sources of zoonoses and zoonotic agents in the European Union in 2009. The EFSA Journal 2011, 9:2090.
13. Evans S. Commentary: matched cohorts can be useful. BMJ 2003, 326:357.
14. Friesema I.H.M., De Jager C.M., Heuvelink A.E., Van der Zwaluw W.K., Kuiling S., Zwartkruis J.T.M., Van Pelt W. Intensieve surveillance van Shiga toxine producerende Escherichia coli in Nederland, 2009. Infectieziekten Bulletin 2011, 22:22-29.
15. Friesema I.H.M., De Jager C.M., Van der Zwaluw W.K., Notermans D.W., Van Heerwaarden C.A.M., Heuvelink A.E., Van der Ende A., Spanjaard L., Van Pelt W. Intensieve surveillance van Listeria monocytogenes in Nederland, 2009. Infectieziekten Bulletin 2011, 22:67-71.
16. Gilbert R.E., Stanford M.R. Is ocular toxoplasmosis caused by prenatal or postnatal infection?. British Journal of Ophthalmology 2000, 84:224-226.
17. Gkogka E., Reij M.W., Havelaar A.H., Zwietering M.H., Gorris L.G.M. Risk-based estimate of effect of foodborne diseases on public health, Greece. Emerging Infectious Diseases 2011, 17:1581-1590.
18. Haagsma J.A., Havelaar A.H., Janssen B.M., Bonsel G.J. Disability Adjusted Life Years and minimal disease: application of a preference-based relevance criterion to rank enteric pathogens. Population Health Metrics 2008, 6:7.
19. Haagsma J.A., Siersema P.D., De Wit N.J., Havelaar A.H. Disease burden of post-infectious irritable bowel syndrome in The Netherlands. Epidemiology and Infection 2010, 138:1650-1656.
20. Hakkaart-van Roijen L., Tan S.S., Bouwmans C.A.M. Handleiding voor kostenonderzoek-Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg 2010, College voor Zorgverzekeringen, Diemen, the Netherlands.
21. Hanevik K., Dizdar V., Langeland N., Hausken T. Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC Gastroenterology 2009, 9:27.
22. Hannu T., Mattila L., Rautelin H., Pelkonen P., Lahdenne P., Siitonen A., Leirisalo-Repo M. Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford, England) 2002, 41:312-318.
23. Havelaar A.H., De Wit M.A., Van Koningsveld R., Van Kempen E. Health burden in the Netherlands due to infection with thermophilic Campylobacter spp. Epidemiology and Infection 2000, 125:505-522.
24. Havelaar A.H., Van Duynhoven Y.T., Nauta M.J., Bouwknegt M., Heuvelink A.E., De Wit G.A., Nieuwenhuizen M.G., van de Kar N.C. Disease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157. Epidemiology and Infection 2004, 132:467-484.
25. Havelaar A.H., Kemmeren J.M., Kortbeek L.M. Disease burden of congenital toxoplasmosis. Clinical Infectious Diseases 2007, 44:1467-1474.
26. Havelaar A.H., Galindo A.V., Kurowicka D., Cooke R.M. Attribution of foodborne pathogens using structured expert elicitation. Foodborne Pathogens and Disease 2008, 5:649-659.
27. Havelaar A.H., Van Pelt W., Ang C.W., Wagenaar J.A., Van Putten J.P., Gross U., Newell D.G. Immunity to campylobacter: its role in risk assessment and epidemiology. Critical Reviews in Microbiology 2009, 35:1-22.
28. Helms M., Vastrup P., Gerner-Smidt P., Molbak K. Short and long term mortality associated with foodborne bacterial gastrointestinal infections: registry based study. BMJ 2003, 326:357.
29. Helms M., Simonsen J., Molbak K. Foodborne bacterial infection and hospitalization: a registry-based study. Clinical Infectious Diseases 2006, 42:498-506.
30. Hofhuis A., Van Pelt W., Van Duynhoven Y.T.H.P., Nijhuis C.D., Mollema L., Van der Klis F.R.M., Havelaar A.H., Kortbeek L.M. Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Netherlands between 1995/1996 and 2006/2007. Epidemiology and Infection 2011, 139:530-538.
31. Jess T., Simonsen J., Nielsen N.M., Jorgensen K.T., Bager P., Ethelberg S., Frisch M. Enteric salmonella or campylobacter infections and the risk of inflammatory bowel disease. Gut 2011, 60:318-324.
32. Jones J.L., Holland G.N. Annual burden of ocular toxoplasmosis in the US. American Journal of Tropical Medicine and Hygien 2010, 82:464-465.
33. Koch J., Wiese-Posselt M. Epidemiology of rotavirus infections in children less than 5years of age: Germany, 2001-2008. Pediatric Infectious Diseases J 2011, 30:112-117.
34. Kortbeek L.M., Hofhuis A., Nijhuis C.D.M., Havelaar A.H. Congenital toxoplasmosis and DALYs in the Netherlands 2009, 104:370-373. Memorias Instituto Oswaldo Cruz.
35. Lake R.J., Cressey P.J., Campbell D.M., Oakley E. Risk ranking for foodborne microbial hazards in New Zealand: burden of disease estimates. Risk Analysis 2010, 30:743-752.
36. Mangen M.-J.J., Havelaar A.H., Bernsen R.A.J.M., Van Koningsveld R., De Wit G.A. The costs of human Campylobacter infections and sequelae in the Netherlands: a DALY and cost-of-illness approach. Acta Agriculturae Scandinavica Section C-Food Economics 2005, 2:35-51.
37. Mann E.A., Saeed S.A. Gastrointestinal infection as a trigger for inflammatory bowel disease. Current Opinion in Gastroenterology 2012, 28:24-29.
38. Marshall J.K., Thabane M., Borgaonkar M.R., James C. Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clinical Gastroenterology and Hepatology 2007, 5:457-460.
39. Morch K., Hanevik K., Rortveit G., Wensaas K.A., Eide G.E., Hausken T., Langeland N. Severity of Giardia infection associated with post-infectious fatigue and abdominal symptoms two years after. BMC Infectious Diseases 2009, 9:206.
40. Morch K., Hanevik K., Rortveit G., Wensaas K.A., Langeland N. High rate of fatigue and abdominal symptoms 2years after an outbreak of giardiasis. Transactions of the Royal Society of Tropical Medicine and Hygien 2009, 103:530-532.
41. Murray C.J. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bulletin of the World Health Organization 1994, 72:429-445.
42. Murray C.J., Acharya A.K. Understanding DALYs (disability-adjusted life years). Journal of Health Economics 1997, 16:703-730.
43. Murray C.J.L., Lopez A.D. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020 1996, Harvard University Press, Cambridge.
44. Murray C.J.L., Lopez A.D., Mathers C.D. Summary Measures of Population Health: Concepts, Ethics, Measurement and Applications 2002, World Health Organization, Geneva.
45. Raybourne R.B., Williams K.M., Roberts T. Food poisoning: economic implications. Encyclopedia of Food Sciences and Nutrition 2003, 2672-2682. Elsevier, London. B. Caballero, L. Trugo, P. Finglas (Eds.).
46. Riddle M.S., Porter C.K. Detection bias and the association between inflammatory bowel disease and Salmonella and Campylobacter infection. Gut 2012, 61(4):635.
47. Scallan E., Griffin P.M., Angulo F.J., Tauxe R.V., Hoekstra R.M. Foodborne illness acquired in the United States-unspecified agents. Emerging Infectious Diseases 2011, 17:16-22.
48. Scallan E., Hoekstra R.M., Angulo F.J., Tauxe R.V., Widdowson M.A., Roy S.L., Jones J.L., Griffin P.M. Foodborne illness acquired in the United States-major pathogens. Emerging Infectious Diseases 2011, 17:7-15.
49. Spiller R., Garsed K. Infection, inflammation, and the irritable bowel syndrome. Digestive and Liver Disease 2009, 41:844-849.
50. Stouthard M.E., Essink-Bot M.L., Bonsel G.J. Disability weights for diseases. A modified protocol and results for a Western European region. European Journal of Public Health 2000, 10:24-30.
51. Tam C.C., Rodrigues L.C., Viviani L., Dodds J.P., Evans M.R., Hunter P.R., Gray J.J., Letley L.H., Rait G., Tompkins D.S., O'Brien S.J. Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut 2012, 61:69-77.
52. Tariq L., Haagsma J., Havelaar A. Cost of illness and disease burden in the Netherlands due to infections with Shiga toxin-producing Escherichia coli O157. Journal of Food Protection 2011, 74:545-552.
53. Van Asten L., Siebenga J., Van den Wijngaard C., Verheij R., Van Vliet H., Kretzschmar M., Boshuizen H., Van Pelt W., Koopmans M. Unspecified gastroenteritis illness and deaths in the elderly associated with norovirus epidemics. Epidemiology 2011, 22:336-343.
54. Van de Laar M.J.W., Wijgergangs L.M., Rijlaarsda J., De Wit A. Vaccineren tegen hepatitis A: een verkenning van kosten. Infectieziekten Bulletin 2000, 11:262-266.
55. Van Kreijl C.F., Knaap A.G.A.C., Van Raaij J.M.A., Busch M.C.M., Havelaar A.H., Kramers P.G.N., Kromhout D., Van Leeuwen F.X.R., Van Leent-Loenen H.M.J.A., Ocké M.C., Verkleij H. Our Food, Our Health-Healthy Diet and Safe Food in the Netherlands 2006, National Institute for Public Health and the Environment, Bilthoven.
56. Van Pelt W., De Wit M.A.S., Wannet W.J.B., Ligtvoet E.J.J., Widdowson M.A., Van Duynhoven Y.T.H.P. Laboratory surveillance of bacterial gastroenteric pathogens in The Netherlands, 1991-2001. Epidemiology and Infection 2003, 130:431-441.
57. Wheeler J.G., Sethi D., Cowden J.M., Wall P.G., Rodrigues L.C., Tompkins D.S., Hudson M.J., Roderick P.J. Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. BMJ 1999, 318:1046-1050.